Evaluation of the Mechanism of Yishan Formula in Treating Breast Cancer Based on Network Pharmacology and Experimental Verification

药物数据库 小桶 AKT1型 系统药理学 计算生物学 乳腺癌 生物 PI3K/AKT/mTOR通路 交互网络 山奈酚 信号转导 基因 药理学 癌症 转录组 基因表达 遗传学 生物化学 槲皮素 药品 抗氧化剂
作者
Xiaoyue Lin,Wencheng Chi,Xue Geng,Qinghui Jiang,Baozhu Ma,Bowen Dai,Yutong Sui,Jiakang Jiang
出处
期刊:Combinatorial Chemistry & High Throughput Screening [Bentham Science]
卷期号:27
标识
DOI:10.2174/0113862073266004231105164321
摘要

Background:: Yishan formula (YSF) has a significant effect on the treatment of breast cancer, which can improve the quality of life and prolong the survival of patients with breast cancer; however, its mechanism of action is unknown. Objective:: In this study, network pharmacology and molecular docking methods have been used to explore the potential pharmacological effects of the YSF, and the predicted targets have been validated by in vitro experiments. Methods:: Active components and targets of the YSF were obtained from the TCMSP and Swiss target prediction website. Four databases, namely GeneCards, OMIM, TTD, and DisGeNET, were used to search for disease targets. The Cytoscape v3.9.0 software was utilized to draw the network of drug-component-target and selected core targets. DAVID database was used to analyze the biological functions and pathways of key targets. Finally, molecular docking and in vitro experiments have been used to verify the hub genes. Results:: Through data collection from the database, 157 active components and 618 genes implicated in breast cancer were obtained and treated using the YSF. After screening, the main active components (kaempferol, quercetin, isorhamnetin, dinatin, luteolin, and tamarixetin) and key genes (AKT1, TP53, TNF, IL6, EGFR, SRC, VEGFA, STAT3, MAPK3, and JUN) were obtained. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis indicated that the YSF could affect the progression of breast cancer by regulating biological processes, such as signal transduction, cell proliferation and apoptosis, protein phosphorylation, as well as PI3K-Akt, Rap1, MAPK, FOXO, HIF-1, and other related signaling pathways. Molecular docking suggested that IL6 with isorhamnetin, MAPK3 with kaempferol, and EGFR with luteolin have strong binding energy. The experiment further verified that YSF can control the development of breast cancer by inhibiting the expression of the hub genes. Conclusion:: This study showed that resistance to breast cancer may be achieved by the synergy of multiple active components, target genes, and signal pathways, which can provide new avenues for breast cancer-targeted therapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
caicaikan完成签到,获得积分10
1秒前
yysh1950发布了新的文献求助10
3秒前
xsx完成签到 ,获得积分10
3秒前
咸菜完成签到,获得积分10
4秒前
4秒前
包容新蕾发布了新的文献求助10
5秒前
嘟嘟小火车完成签到,获得积分10
6秒前
bkagyin应助存存采纳,获得10
6秒前
Hubert完成签到 ,获得积分10
7秒前
ding应助梨llll采纳,获得30
8秒前
西城锡城完成签到,获得积分10
8秒前
从容芮应助11111采纳,获得10
8秒前
情怀应助ggg采纳,获得10
10秒前
planto完成签到,获得积分10
11秒前
melon完成签到,获得积分10
11秒前
13秒前
lightman完成签到,获得积分10
13秒前
14秒前
西西里完成签到,获得积分10
15秒前
领导范儿应助啊哈采纳,获得10
15秒前
北觅完成签到 ,获得积分10
15秒前
18秒前
19秒前
风中乐曲完成签到,获得积分10
19秒前
在水一方应助刀锋采纳,获得10
19秒前
19秒前
李健应助简单的依珊采纳,获得10
19秒前
Jasper应助陈梦鼠采纳,获得10
19秒前
21秒前
华仔应助反杀闰土的猹采纳,获得10
21秒前
22秒前
大小王完成签到,获得积分10
23秒前
yysh1950完成签到,获得积分10
23秒前
23秒前
jojo发布了新的文献求助10
24秒前
LI完成签到,获得积分20
24秒前
小二郎应助move采纳,获得10
25秒前
25秒前
高分求助中
Earth System Geophysics 1000
Semiconductor Process Reliability in Practice 650
Studies on the inheritance of some characters in rice Oryza sativa L 600
Medicina di laboratorio. Logica e patologia clinica 600
《关于整治突出dupin问题的实施意见》(厅字〔2019〕52号) 500
Mathematics and Finite Element Discretizations of Incompressible Navier—Stokes Flows 500
Language injustice and social equity in EMI policies in China 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3207260
求助须知:如何正确求助?哪些是违规求助? 2856664
关于积分的说明 8106335
捐赠科研通 2521831
什么是DOI,文献DOI怎么找? 1355240
科研通“疑难数据库(出版商)”最低求助积分说明 642172
邀请新用户注册赠送积分活动 613472